Putative mesenchymal stem cells isolated from adult human ovaries
- 206 Downloads
The purpose of this study was to show that healthy adult human ovaries can be a source of cells showing typical MSCs characteristics under in vitro conditions.
Methods and results
The cells, which were isolated from ovarian cortex tissue and named putative ovarian mesenchymal stem cells (PO-MSCs), were compared to bone marrow-derived MSCs (BM-MSCs) and to adult human dermal fibroblasts (HDFs). The results of a gene expression analysis using the Human Mesenchymal Stem Cell RT² Profiler™ PCR Array revealed that PO-MSCs were different than fibroblasts. They expressed most of the analyzed genes as BM-MSCs, although some genes were differentially expressed. However, the heterogeneity of PO-MSCs samples was revealed. The PO-MSCs expressed the characteristic genes related to MSCs, such as CD105, CD44, CD90, M-CAM, CD73 and VCAM1. In addition, the expression of markers CD44, CD90, M-CAM and STRO-1 was confirmed in PO-MSCs using immunocytochemistry. The PO-MSCs showed multipotent character, since they were able to differentiate into the cells of adipogenic, osteogenic, neural and pancreatic lineage.
Healthy adult human ovaries can harbour an interesting population of cells showing typical MSCs characteristics under in vitro conditions and for this reason we named these cells putative MSCs. These cells express genes encoding main MSCs markers and have an interesting differential potential. Based on these results, we propose PO-MSCs as a novel type of MSCs which share some similarities with BM-MSCs. Nevertheless they show distinct and specific characteristics and are not fibroblasts.
KeywordsOvary Mesenchymal stem cells Bone marrow Gene expression Multipotency
The authors would like to thank Dr. Branko Cvjeticanin, Department of Obstetrics and Gynecology, University Medical Centre Ljubljana, for providing the ovarian tissue biopsies, to all patients who donated ovarian tissue for this research, to Dr. Elvira Malicev and Prof. Primoz Rozman, the Blood Transfusion Centre of Ljubljana for providing flow-cytometry analysis, to all the colleagues at the Reproductive Unit of our department and to the Slovenian Research Agency (grant J3-4195 to Dr. Irma Virant-Klun) for financial support.
The authors declare that they have no conflict of interests.
- 10.da Silva ML, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006;119(Pt 11):2204–13.Google Scholar
- 16.Trubiani O, Zalzal SF, Paganelli R, Marchisio M, Giancola R, Pizzicannella J, et al. Expression profile of the embryonic markers nanog, OCT-4, SSEA-1, SSEA-4, and frizzled-9 receptor in human periodontal ligament mesenchymal stem cells. J Cell Physiol. 2010;225(1):123–31.PubMedCrossRefGoogle Scholar
- 18.Sun Y, Chen L, Hou XG, Hou WK, Dong JJ, Sun L, et al. Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro. Chin Med J (Engl). 2007;120(9):771–6.Google Scholar
- 24.Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3:3.Google Scholar
- 41.Russell KC, Phinney DG, Lacey MR, Barrilleaux BL, Meyertholen KE, O’Connor KC. In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells. 2010;28(4):788–98.PubMedCrossRefGoogle Scholar
- 52.Boroujeni Z, Aleyasin A. Human Umbilical Cord Derived Mesenchymal Stem Cells Can Secret Insulin In Vitro and In Vivo. Biotechnol Appl Biochem. May 31 2013; doi: 10.1002/bab.1127 [Epub ahead of print].